A novel recombinant javanicin with dual antifungal and anti-proliferative activities
© 2019, The Author(s). Resistance to common drugs by microorganisms and cancers has become a major issue in modern healthcare, increasing the number of deaths worldwide. Novel therapeutic agents with a higher efficiency and less side effects for the treatment of certain diseases are urgently needed....
Saved in:
Main Authors: | Santhasiri Orrapin, Amornrat Intorasoot, Sittiruk Roytrakul, Nathupakorn Dechsupa, Jiraporn Kantapan, Yanika Onphat, Chutima Srimek, Chayada Sitthidet Tharinjaroen, Usanee Anukool, Bordin Butr-Indr, Ponrut Phunpae, Sorasak Intorasoot |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075967653&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68117 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Novel targeting of the lepB gene using PCR with confronting two-pair primers for simultaneous detection of Mycobacterium tuberculosis complex and Mycobacterium bovis
by: Chayada Sitthidet Tharinjaroen, et al.
Published: (2018) -
Genotypic distribution and a potential diagnostic assay of multidrug-resistant tuberculosis in northern thailand
by: Usanee Anukool, et al.
Published: (2020) -
Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro
by: Manlika Wanmakok, et al.
Published: (2018) -
Recombinant expression of novel protegrin-1 dimer and LL-37-linker- histatin-5 hybrid peptide mediated biotin carboxyl carrier protein fusion partner
by: Santhasiri Orrapin, et al.
Published: (2018) -
Recombinant expression of novel protegrin-1 dimer and LL-37-linker- histatin-5 hybrid peptide mediated biotin carboxyl carrier protein fusion partner
by: Santhasiri Orrapin, et al.
Published: (2018)